SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-09-002379
Filing Date
2009-03-09
Accepted
2009-03-09 17:06:35
Documents
5
Period of Report
2009-04-24
Effectiveness Date
2009-03-09

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2191301zdef14a.htm DEF 14A 741145
2 G817752.JPG g817752.jpg GRAPHIC 6750
3 G979546.JPG g979546.jpg GRAPHIC 3974
4 G352051.JPG g352051.jpg GRAPHIC 6598
5 G19163MAI001.JPG g19163mai001.jpg GRAPHIC 741
  Complete submission text file 0001047469-09-002379.txt   768131
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-30319 | Film No.: 09666893
SIC: 2834 Pharmaceutical Preparations